Prognostic significance of loss of chromosome 10 in high grade gliomas.

被引：0
|
作者：
Balesaria, S
Brock, C
Bower, M
Lewis, P
Newlands, ES
Fisher, RA
机构：
[1] Charing Cross Hosp, Imperial Coll Sch Med, Dept Canc Med, London, England
[2] Charing Cross Hosp, Imperial Coll Sch Med, Dept Histopathol, London, England
来源：
BRITISH JOURNAL OF CANCER | 1999年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5
引用
收藏
页码：30 / 30
页数：1
相关论文
共 50 条
  • [41] A phase II trial of LY317615 in patients with recurrent high grade gliomas.
    Fine, HA
    Kim, L
    Royce, C
    Mitchell, S
    Duic, JP
    Albert, P
    Musib, L
    Thornton, D
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 109S - 109S
  • [42] Prognostic significance of imaging contrast enhancement for WHO grade II gliomas
    Pallud, Johan
    Capelle, Laurent
    Taillandier, Luc
    Fontaine, Denys
    Mandonnet, Emmanuel
    Guillevin, Remy
    Bauchet, Luc
    Peruzzi, Philippe
    Laigle-Donadey, Florence
    Kujas, Michele
    Guyotat, Jacques
    Baron, Marie-Helene
    Mokhtari, Karima
    Duffau, Hugues
    NEURO-ONCOLOGY, 2009, 11 (02) : 176 - 182
  • [43] The prognostic significance of PTEN promoter hypermethylation in low-grade gliomas
    McBride, Sean M.
    Smith, Justin S.
    Zheng, Shichun
    Chang, Edward F.
    Berger, Kathleen S.
    Stokoe, David
    Haas-Kogan, Daphne
    NEURO-ONCOLOGY, 2007, 9 (04) : 542 - 543
  • [44] Loss of heterozygosity of chromosome 10p in human gliomas
    Kimmelman, AC
    Ross, DA
    Liang, BC
    GENOMICS, 1996, 34 (02) : 250 - 254
  • [45] Synergistic effect of reirradiation and PD-1 inhibitors in recurrent high-grade gliomas.
    Iwamoto, Fabio Massaiti
    Donovan, Laura
    Schaff, Lauren R.
    Wang, Tony J. C.
    Lassman, Andrew B.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07)
  • [46] A neurosurgeon's perspective on the neuropathology of low-grade gliomas.
    Piepmeier J.M.
    Brain Tumor Pathology, 2000, 17 (2) : 85 - 88
  • [47] BIOLOGIC AND CLINICAL SIGNIFICANCE OF NEOPLASTIC AND MYELOID STATES IN DIFFUSE GLIOMAS.
    Mehani, Bharati
    Asanigari, Saleembhasha
    Chung, Hye-Jung
    Dazelle, Karen
    Aldape, Kenneth
    NEURO-ONCOLOGY, 2022, 24 : 156 - 156
  • [48] Molecular targeting with engineered interleukin 13 for imaging and treatment of human high-grade gliomas.
    Debinski, W
    Thompson, JP
    Gilbo, DM
    Slagle, B
    CLINICAL CANCER RESEARCH, 1999, 5 : 3804S - 3805S
  • [49] A phase I trial of intravenous liposomal irinotecan in patients with recurrent high-grade gliomas.
    Clarke, Jennifer Leigh
    Molinaro, Annette M.
    DeSilva, Ashley A.
    Rabbitt, Jane E.
    Drummond, Daryl C.
    Chang, Susan Marina
    Butowski, Nicholas A.
    Prados, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [50] High glycolysis in gliomas despite low hexokinase transcription and activity correlated to chromosome 10 loss
    Oudard, S
    Arvelo, F
    Miccoli, L
    Apiou, F
    Dutrillaux, AM
    Poisson, M
    Dutrillaux, B
    Poupon, MF
    BRITISH JOURNAL OF CANCER, 1996, 74 (06) : 839 - 845
12345